Lansoprazole is an uncompetitive inhibitor of tissue-nonspecific alkaline phosphatase

Acta Biochimica Polonica

Volumn 56, Issue 2, 2009, Pages 301-306

  Delomenède, Mélanie ^a   Buchet, René ^a   Mebarek, Saïda ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

Alkaline phosphatase; Inhibition; Lansoprazole; Osteoarthritis; PHOSPHO1; Phosphocholine

Indexed keywords

EID: 68249122934     PISSN: 0001527X     EISSN: 1734154X     Source Type: Journal    
DOI: 10.18388/abp.2009_2462     Document Type: Article

References (37)

1. Ali SY (1985) Apatite-type crystal deposition in arthritic cartilage. Scan Electron Microsc 4: 1555-1566.
2. Anderson HC (1983) Calcific diseases, A concept. Arch. Pathol Lab Med 107: 341-348.
3. Anderson HC (1988) Mechanisms of pathological calcification. Rheum Dis Clin North Am 14: 303-319.
4. Anderson HC (2007) The role of matrix vesicles in physiological and pathological calcification. Curr Opin Orthop 18: 428-433.
5. Anderson HC, Sipe JB, Hessle L, Dhanyamraju R, Atti E, Camacho NP (2004) Impaired calcification around matrix vesicles of growth plate and bone in alkaline phos-phatase- deficient mice. Am J Pathol 164: 841-847.
6. Balcerzak M, Hamade E, Zhang L, Pikula S, Azzar G, Radisson J, Bandorowicz-Pikula J, Buchet R (2003) The roles of annexins and alkaline phosphatase in mineralization process. Acta Biochim Polon 50: 1019-1038.
7. Balcerzak M, Pikula S, Buchet R (2006) Phosphorylationdependent phospholipase D activity of matrix vesicles. FEBS Lett 580: 5676-5680.
8. Balcerzak M, Radisson J, Azzar G, Farlay D, Boivin G, Pikula S, Buchet R (2007) A comparative analysis of strategies for isolation of matrix vesicles. Anal Biochem 361: 176-182.
9. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utiliz-ing the principle of protein-dye binding. Anal Biochem 72: 248-254.
10. Besancon M, Simon A, Sachs G, Shin JM (1997) Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents. J Biol Chem 272: 22438-22446.
11. Carroll GJ, Stuart RA, Armstrong JA, Breidahl BA, Laing BA (1991) Hydroxyapatite crystals are a frequent finding in osteoarthritis synovial fluid, but are not related to increased concentrations of keratan sulfate or interleukin 1 beta. J Rheumatol 18: 861-866.
12. Cyboron GW, Wuthier RE (1981) Purification and initial characterization of intrinsic membrane-bound alkaline phosphatase from chicken epiphyseal cartilage. J Biol Chem 256: 7262-7268.
13. Der G (2003) An overview of proton pump inhibitor. Gastroenterol Nurs 26: 182-190.
14. Derfus BA, Kurian JB, Butler JJ, Daft LJ, Carrera GF, Ryan LM, Rosenthal AK (2002) The high prevalence of pathologic calcium crystals in preoperatives knees. J Rheumatol 29: 570-574.
15. DeVault KR, Castel DO (1999) Updated guidelines for the diagnosis and treatment of gastroeosophageal reflux disease. The Practise Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 94: 1434-1442.
16. Einhorn TA, Gordon SL, Siegel SA, Hummel CF, Avitable MJ, Carty RP (1985) Matrix vesicle enzymes in human osteoarthritis. J Orthop Res 3: 160-169.
17. Engstrom L (1961) Studies on calf-intestinal alkaline phosphatase. I. Chromatographic purification, microheterogeneity and some other properties of the purified enzyme. Biochim Biophys Acta 52: 36-48.
18. Gordon GV, Villanueva T, Schumacher HR, Gohel V (1984) Autopsy study correlating degree of osteoarthritis, synovitis and evidence of articular calfication. J Rheumatol 11: 681-688.
19. Gremse DA (2001) Lansoprazole: pharmacokinetics, pharmacodynamics and clinical use. Expert Opin Pharmacother 2: 1663-1670.
20. Hsu HHT, Anderson HC (1996) Evidence of the presence of a specific ATPase responsible for ATP-initiated calcification by matrix vesicles isolated from cartilage and bone. J Biol Chem 271: 26383-26388.
21. Hsu HHT, Camacho NP, Anderson HC (1999) Further characterization of ATP-initiated calcification by matrix vesicles isolated from rachitic rat cartilage. Membrane perturbation by detergents and deposition of calcium pyrophosphate by rachitic matrix vesicles. Biochim Biophys Acta 1416: 320-332.
22. Kirsch T (2007) Physiological and pathological calcification: a complex multifactorial process. Curr Opin Orthop 18: 425-427.
23. Kivioja A, Linnosmaa I, Vehviläinen A, Vohlonen L (2004) Cost-minimization analysis of treatment of gastro-esophageal reflux disease: implications of varying holding time on coclusions. Eur J Pharm Sci 21: 171-178.
24. McGill PE (1976) Levamisole in rheumatoid arthritis. Lancet 1: 149.
25. Miller B, Demerieux P, Spinivasan R, Clemments P, Fan P, Levy J, Paulus HE (1980) Double-blind placebo-controlled cross-over evaluation of levamisole in rheumatoid arthritis. Arthritis Rheum 23: 172-182.
26. Nalbant S, Martinez JA, Kitumnuaypong T, Clayburne G, Sieck M, Schumacher Jr HR (2003) Synovial fluid features and their relations to osteoarthritis severity: new. findings from sequential studies. Osteoarthritis Cartilage 11: 50-54.
27. Narisawa S, Harmey D, Yadav MC, O'Neill WC, Hoylaerts MF, Millán JL (2007) Novel inhibitors of alkaline phosphatase suppress vascular smooth cell calcification. J Bone Miner Res 22: 1700-1710.
28. 32 uptake and mineralization by matrix vesicle-enriched fractions and by hydroxyapatite. Bone 6: 307-312.
29. Register TC, McLean FM, Low MG, Wuthier RE (1986) Roles of alkaline phosphatase and labile internal mineral in matrix vesicle-mediated calcification. J Biol Chem 261: 9354-9360.
30. Roberts SJ, Stewart AJ, Sadler PJ, Farquharson C (2004) Human PHOSPHO1 displays high specific phosphoeth-anolamine and phosphocholine phosphatase activity. Biochem J 382: 59-65.
31. Roberts SSJ, Stewart AJ, Schmid R, Blindauer CA, Bond SR, Sadler PJ, Farquharson C (2005) Probing substrate specificities of human PHOSPHO1 and PHOSPHO2. Biochim Biophys Acta 1752: 73-82.
32. Roberts SJ, Stewart AJ, Seawright E, Davey E, Fleming MG, Farquharson C (2006) The presence of PHOSPHO1 in matrix vesicles and its developmental expression prior to skeletal mineralization. Bone 39: 1000-1007.
33. Roberts SJ, Narisawa S, Harmey D, Milan JL, Farquharson C (2007) Functional involvement of PHOSPHO1 in matrix vesicle-mediated skeletal mineralization. J Bone Miner Res 22: 617-627.
34. Shi S, Klotz U (2008) Proton pump inhibitors: an update of their clinical use and pharmacokinetics. Eur J Clin Pharmacol 64: 935-951.
35. Sidique S, Ardecky R, Su Y, Narisawa S, Brown B, Millan JL, Sergienko E, Cosford DP (2009) Design and synthesis of pyrazole derivatives as potent and selective inhibitors of tissue-nonspecific alkaline phosphatase (TNAP). Biorg Med Chem Lett 19: 222-225.
36. Wu LN, Genge BR, Dunkelberger DG, LeGeros RZ, Concannon B, Wuthier R (1997) Physicochemical characterization of the nucleational core of matrix vesicles. J Biol Chem 272: 4404-4411.
37. Zhang L, Balcerzak M, Radisson J, Thouverey C, Pikula S, Azzar G, Buchet R (2005) Phosphodiesterase activity of alkaline phosphatase in ATP-initiated Ca2+ and phosphate deposition in isolated chicken matrix vesicles. J Biol Chem 280: 37289-37296